{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/ofix-stock-analysis/",
 "dataUrl": "https://clearank.com/stock/ofix-stock-analysis/data.json",
 "title": "Orthofix Medical (OFIX) Stock Forecast & Price Target (2026)",
 "description": "Orthofix Medical Inc. (OFIX) stock: Healthcare, Medical Devices. $360M market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Orthofix Medical Inc. (OFIX)",
 "published": "2026-07-22T09:35:25+00:00",
 "modified": "2026-09-11T20:37:46.516+00:00",
 "generated": "2026-09-11T21:01:07.233Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "OFIX",
  "name": "Orthofix Medical Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Medical Devices",
  "country": "United States",
  "website": "https://orthofix.com"
 },
 "quote": {
  "price": 8.91,
  "previousClose": 8.69,
  "change": 0.22,
  "changePercent": 2.53,
  "open": 8.83,
  "high": 8.99,
  "low": 8.62,
  "volume": 30400,
  "averageVolume": 314740,
  "marketCap": 360156919,
  "fiftyTwoWeekHigh": 16.99,
  "fiftyTwoWeekLow": 8.62,
  "marketOpen": false,
  "asOf": "2026-09-11T20:37:45.000Z"
 },
 "statistics": {
  "pe": -3.8240343347639483,
  "eps": -1.48,
  "dividendYield": 0,
  "beta": 0.646,
  "priceToSales": 0.43226475,
  "priceToBook": 0.8455917,
  "revenueTtm": 833185984,
  "grossMargin": 0.7097372151346636,
  "returnOnEquity": -0.13909
 },
 "technicals": {
  "rsi": 22.22,
  "macd": -0.46,
  "sma50": 10.61,
  "sma200": 12.18,
  "rsiSignal": "Oversold",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 59,
  "consensus": "Hold",
  "fairValue": 13,
  "analystTarget": 13,
  "analystCount": 5,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-11T20:37:45.000Z",
  "priceAtAnalysis": 8.91,
  "volatility": {
   "daily": 3.25,
   "risk": "volatile"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 8.82,
  "aggressiveEntry": 8.91,
  "stopLoss": 8.14,
  "stopLossPercent": 7.7,
  "targets": [
   9.09,
   9.26,
   9.53
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 4.93,
    "base": 8.41,
    "upside90th": 14.35
   },
   {
    "year": 2028,
    "downside10th": 3.73,
    "base": 7.93,
    "upside90th": 16.9
   },
   {
    "year": 2029,
    "downside10th": 2.97,
    "base": 7.49,
    "upside90th": 18.9
   },
   {
    "year": 2030,
    "downside10th": 2.43,
    "base": 7.07,
    "upside90th": 20.58
   },
   {
    "year": 2031,
    "downside10th": 2.02,
    "base": 6.67,
    "upside90th": 22.03
   },
   {
    "year": 2032,
    "downside10th": 1.7,
    "base": 6.29,
    "upside90th": 23.3
   },
   {
    "year": 2033,
    "downside10th": 1.44,
    "base": 5.94,
    "upside90th": 24.42
   },
   {
    "year": 2034,
    "downside10th": 1.24,
    "base": 5.6,
    "upside90th": 25.41
   },
   {
    "year": 2035,
    "downside10th": 1.06,
    "base": 5.29,
    "upside90th": 26.28
   },
   {
    "year": 2036,
    "downside10th": 0.92,
    "base": 4.99,
    "upside90th": 27.05
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "OFIX Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$8.83",
    "Day Range": "$8.62 to $8.99",
    "Prev Close": "$8.69",
    "Volume": "30.4K",
    "52-Week Range": "$8.62 to $16.99",
    "Market Cap": "$360.16M"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis On price-to-sales, the yardstick used here in place of P/E, OFIX trades at 0.4323x, far below the sector average of 3.70x."
   ]
  },
  {
   "id": "financials",
   "title": "OFIX Financial Performance",
   "text": [
    "Analysis: In the last 2 quarters, OFIX beat estimates 1 times. However, the stock fell 1 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "OFIX Analysis",
   "text": [
    "Orthofix Medical Inc. is trading below its 50-day SMA of $10.61 and its 200-day SMA of $12.18, indicating a bearish trend. The RSI is at 22.22, firmly in oversold territory, suggesting potential for a short-term rebound. MACD is at -0.46, also pointing to bearish momentum, while the CCI at -124.81 reinforces the oversold condition. Volume has been significantly below average, down 90.3% compared to its average of 314,740, which could limit the impact of any potential upward price movement. The current price action suggests that key moving averages are acting as resistance. Investors should watch for a sustained break above the 50-day SMA to signal a potential shift in momentum.",
    "Insiders have invested $5.5 million in net purchases, indicating a degree of confidence in the company's future prospects, particularly from ENGINE CAPITAL MANAGEMENT, L.L.C.",
    "The Q2 2026 earnings report showed a 333.33% EPS surprise ($0.07 actual vs. -$0.03 estimate), driving a positive stock reaction and suggesting improving operational efficiency.",
    "With a median price target of $13.00, analysts suggest a 45.9% upside, but the 'Hold' rating indicates a balanced view on the stock's near-term prospects.",
    "The company continues to report negative EPS and its revenue growth lags behind the healthcare sector median, posing a fundamental challenge to valuation.",
    "Orthofix Medical Inc. faces a challenging outlook, with its current price action and negative EPS suggesting continued pressure unless operational improvements gain significant traction. The median analyst target price of $13.00 implies a potential upside of 45.9%, but this is contingent on the company achieving sustained profitability and accelerating revenue growth towards sector averages. Key catalysts for a positive shift would include continued strong earnings beats, successful integration of acquired businesses, and positive clinical trial data or product approvals. Conversely, a failure to improve margins, increased competition, or a slowdown in the medical device market could lead to further downside, potentially testing the lower end of analyst targets and long-range projections."
   ],
   "lists": {
    "ProTips": [
     "Monitor upcoming earnings reports closely for continued EPS beats and revenue growth acceleration to validate the recent positive surprise.",
     "Given the oversold RSI, consider that a short-term technical bounce is possible, but fundamental improvements are needed for sustained upside.",
     "The significant insider buying provides a degree of confidence, but investors should still exercise caution due to the company's negative profitability and below-sector-average growth metrics."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Significant Insider Net Buying",
     "text": "Insiders have invested $5.5 million in net purchases, indicating a degree of confidence in the company's future prospects, particularly from ENGINE CAPITAL MANAGEMENT, L.L.C.",
     "source": "Insider Transactions"
    },
    {
     "type": "Bullish",
     "title": "Strong Earnings Beat",
     "text": "The Q2 2026 earnings report showed a 333.33% EPS surprise ($0.07 actual vs. -$0.03 estimate), driving a positive stock reaction and suggesting improving operational efficiency.",
     "source": "Earnings Report"
    },
    {
     "type": "Neutral",
     "title": "Wall Street 'Hold' Consensus",
     "text": "With a median price target of $13.00, analysts suggest a 45.9% upside, but the 'Hold' rating indicates a balanced view on the stock's near-term prospects.",
     "source": "Analyst Ratings"
    },
    {
     "type": "Bearish",
     "title": "Negative EPS and Below-Sector Revenue Growth",
     "text": "The company continues to report negative EPS and its revenue growth lags behind the healthcare sector median, posing a fundamental challenge to valuation.",
     "source": "Financial Statements"
    }
   ],
   "links": [
    {
     "text": "CCI",
     "url": "https://clearank.com/stock/cci-stock-analysis/"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Orthofix Medical Inc. exhibits a challenging fundamental profile, with a negative EPS of -1.48 rendering its P/E ratio of -3.82 (negative due to EPS of $-1.48). The company's revenue growth of 3.8% is below the Healthcare sector's median of 8.1%. While the recent earnings report showed a significant positive surprise of 333.33% ($0.07 actual vs. -$0.03 estimate), this follows a pattern of mixed results and does not yet translate to overall profitability. The valuation appears stretched given the lack of profitability and below-average growth. However, the median analyst price target of $13.00 suggests that Wall Street sees potential for recovery, offering a 45.9% upside from the current price. The significant insider net buying, totaling $5.5 million, could indicate management's belief in the company's turnaround potential, despite current financial metrics.",
    "Orthofix Medical Inc. reported a substantial earnings beat in its most recent quarter ending August 5, 2026, with actual EPS of $0.07 significantly exceeding the estimated -$0.03, a 333.33% surprise. This positive result followed a period of mixed earnings, including a break-even quarter and a prior miss. The stock saw a 1.73% price increase following this latest earnings announcement, suggesting a favorable market reaction to the improved performance.",
    "Orthofix Medical Inc. faces significant risks including its persistent negative EPS and below-sector-average revenue growth, which challenge its long-term profitability and valuation. The stock is trading below key moving averages, indicating a bearish technical trend that could continue if fundamental improvements do not materialize. Also, while recent insider buying is a positive signal, the overall financial health and path to consistent profitability remain key concerns for investors."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "360.16M"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "N/A (Negative EPS)"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "-1.48"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "16.99"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "8.62"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Oversold SMA Cross Bearish Price vs SMA Bearish MACD Bearish Moving averages show a lagging Death Cross (50-day: $10.61, 200-day: $12.18), price is trading below the 50-day SMA, RSI at 22.2 suggests oversold conditions; potential bounce setup."
   ],
   "facts": {
    "RSI": "Oversold",
    "SMA Cross": "Bearish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "22.22"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-0.46"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "10.61"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "12.18"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.34",
    "Correlation with Nasdaq 100 (QQQ)": "+0.24",
    "Correlation with Bitcoin (BTC)": "-0.05",
    "Correlation with Gold (XAU)": "-0.04"
   }
  },
  {
   "id": "trade-plans",
   "title": "OFIX Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (22.2) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$9.086",
    "TARGET 2": "$9.262",
    "TARGET 3": "$9.527",
    "STOP LOSS": "$8.142"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "-0.52%",
    "Average Feb return": "-0.18%",
    "Average Mar return": "-4.87%",
    "Average Apr return": "+3.69%",
    "Average May return": "-5.66%",
    "Average Jun return": "-1.17%",
    "Average Jul return": "+5.86%",
    "Average Aug return": "+1.92%",
    "Average Sep return": "-5.47%",
    "Average Oct return": "-3.80%",
    "Average Nov return": "+3.90%",
    "Average Dec return": "+1.96%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "3.25%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in OFIX in September 2016 would be worth about $1,983 today, compared with about $35,030 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in OFIX today could grow to about $5,601 by 2036 in the base case, with a bull case near $30,358 and a bear case around $1,034. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "OFIX Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $7.07 for OFIX by 2030 in the base case, from $8.91 today (0.8x over 4 years). The downside path ends near $2.43. These are outcomes of a Monte Carlo simulation run on OFIX's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using OFIX's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "OFIX simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$4.93",
        "$8.41",
        "$14.35"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$3.73",
        "$7.93",
        "$16.90"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$2.97",
        "$7.49",
        "$18.90"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$2.43",
        "$7.07",
        "$20.58"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$2.02",
        "$6.67",
        "$22.03"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$1.70",
        "$6.29",
        "$23.30"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$1.44",
        "$5.94",
        "$24.42"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$1.24",
        "$5.60",
        "$25.41"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$1.06",
        "$5.29",
        "$26.28"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$0.9209",
        "$4.99",
        "$27.05"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "QDEL QuidelOrtho Corporation NASDAQ $12.15 -3.88%",
     "url": "https://clearank.com/stock/quidelortho-qdel/"
    },
    {
     "text": "VKTX Viking Therapeutics, Inc. NASDAQ $32.13 -1.74%",
     "url": "https://clearank.com/stock/viking-therapeutics-vktx/"
    },
    {
     "text": "AGL agilon health, Inc. NYSE $92.60 -1.06%",
     "url": "https://clearank.com/stock/agl-stock-analysis/"
    },
    {
     "text": "NEOG Neogen Corp. NASDAQ $11.81 +0.3398%",
     "url": "https://clearank.com/stock/neogen-neog/"
    },
    {
     "text": "MRK Merck & Co., Inc. NYSE $147.53 -0.6264%",
     "url": "https://clearank.com/stock/merck-mrk/"
    },
    {
     "text": "MCK McKesson Corporation NYSE $880.86 -1.21%",
     "url": "https://clearank.com/stock/mck-stock-analysis/"
    },
    {
     "text": "JNJ Johnson & Johnson NYSE $265.63 -0.2703%",
     "url": "https://clearank.com/stock/johnson-johnson-jnj/"
    },
    {
     "text": "LEGN Legend Biotech Corporation NASDAQ $19.91 -2.83%",
     "url": "https://clearank.com/stock/legend-biotech-legn/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "SCHD vs VOO Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/schd-vs-voo/"
    },
    {
     "text": "AMD vs MU Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/amd-vs-mu/"
    },
    {
     "text": "VTI vs VT Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vti-vs-vt/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "OFIX Insider Trading Analysis",
   "facts": {
    "Bought": "$5.5M",
    "Sold": "$3.7M",
    "Insiders": "19",
    "Avg Transaction": "$297.4K"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in OFIX",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "May 22, 2026",
       "cells": [
        "JUNIPER INVESTMENT COMPANY, LLC Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "242.0K",
        "$2.6M"
       ]
      },
      {
       "label": "Jun 20, 2018",
       "cells": [
        "FUJIKAWA RAYMOND Officer",
        "Sell",
        "32.2K",
        "$1.9M"
       ]
      },
      {
       "label": "Jun 18, 2018",
       "cells": [
        "FINEGAN MICHAEL M Officer",
        "Sell",
        "30.0K",
        "$1.8M"
       ]
      },
      {
       "label": "Feb 19, 2019",
       "cells": [
        "BIANCHI DAVIDE Officer",
        "Sell",
        "24.4K",
        "$1.6M"
       ]
      },
      {
       "label": "Sep 1, 2016",
       "cells": [
        "FINEGAN MICHAEL M Officer",
        "Sell",
        "25.0K",
        "$1.1M"
       ]
      },
      {
       "label": "Jun 19, 2018",
       "cells": [
        "BIANCHI DAVIDE Officer",
        "Sell",
        "14.8K",
        "$885.7K"
       ]
      },
      {
       "label": "Jun 9, 2016",
       "cells": [
        "MASON BRADLEY R Chief Executive Officer",
        "Sell",
        "18.3K",
        "$843.5K"
       ]
      },
      {
       "label": "Jul 3, 2018",
       "cells": [
        "NIEMANN BRADLEY V Officer",
        "Sell",
        "11.3K",
        "$641.4K"
       ]
      },
      {
       "label": "May 20, 2016",
       "cells": [
        "GOODWIN ROBERT ALLEN II Officer",
        "Sell",
        "13.2K",
        "$580.2K"
       ]
      },
      {
       "label": "May 14, 2019",
       "cells": [
        "MASON BRADLEY R Chief Executive Officer",
        "Sell",
        "10.7K",
        "$573.0K"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Orthofix+Medical+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is Orthofix Medical Inc.'s stock forecast for 2030?",
   "answer": "Orthofix Medical Inc.'s stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $7.07, with a downside scenario at $2.43 and an upside scenario at $20.58. These figures represent statistical outcomes and are not guaranteed price targets."
  },
  {
   "question": "Is Orthofix Medical Inc. stock a buy right now?",
   "answer": "Orthofix Medical Inc. (OFIX) is currently rated a 'Hold' by Wall Street analysts, with a median price target of $13.00, suggesting a 45.9% upside from its current price of $8.91. The stock is technically oversold, but its negative EPS and below-sector-average revenue growth present considerable risks."
  },
  {
   "question": "What are the biggest risks facing Orthofix Medical Inc.?",
   "answer": "The primary risks for Orthofix Medical Inc. include its ongoing negative earnings per share, revenue growth that lags its healthcare sector peers, and a bearish technical trend indicated by its position below key moving averages. The company's ability to achieve consistent profitability and outpace sector growth are critical factors."
  },
  {
   "question": "How did Orthofix Medical Inc. perform in its latest earnings report?",
   "answer": "In its latest earnings report on August 5, 2026, Orthofix Medical Inc. reported an EPS of $0.07, significantly beating the estimated -$0.03 by 333.33%. This positive surprise led to a 1.73% increase in the stock price."
  },
  {
   "question": "What is the consensus rating for OFIX stock?",
   "answer": "The consensus rating for OFIX stock among Wall Street analysts is 'Hold', supported by a consensus score of 70 out of 100. This rating reflects a balanced view among the five analysts covering the company."
  },
  {
   "question": "Are insiders buying Orthofix Medical Inc. stock?",
   "answer": "Yes, insiders are net sellers of Orthofix Medical Inc. stock, with total purchases of $5.5 million compared to $3.7 million in sales. This activity, particularly from ENGINE CAPITAL MANAGEMENT, L.L.C., has resulted in a 'Slight Buy Signal' according to insider transaction data."
  },
  {
   "question": "How does Orthofix Medical Inc. compare to its sector averages?",
   "answer": "Orthofix Medical Inc.'s revenue growth of 3.8% is below the Healthcare sector median of 8.1%, and its P/E ratio of -6.02 (negative due to EPS of $-1.48). Its Return on Equity (ROE) is also negative compared to the sector's median of 6.9%."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "QDEL",
    "name": "QuidelOrtho Corporation NASDAQ",
    "price": "$12.15",
    "change": "-3.88%",
    "url": "https://clearank.com/stock/quidelortho-qdel/"
   },
   {
    "ticker": "VKTX",
    "name": "Viking Therapeutics, Inc. NASDAQ",
    "price": "$32.13",
    "change": "-1.74%",
    "url": "https://clearank.com/stock/viking-therapeutics-vktx/"
   },
   {
    "ticker": "AGL",
    "name": "agilon health, Inc. NYSE",
    "price": "$92.60",
    "change": "-1.06%",
    "url": "https://clearank.com/stock/agl-stock-analysis/"
   },
   {
    "ticker": "NEOG",
    "name": "Neogen Corp. NASDAQ",
    "price": "$11.81",
    "change": "+0.3398%",
    "url": "https://clearank.com/stock/neogen-neog/"
   },
   {
    "ticker": "MRK",
    "name": "Merck & Co., Inc. NYSE",
    "price": "$147.53",
    "change": "-0.6264%",
    "url": "https://clearank.com/stock/merck-mrk/"
   },
   {
    "ticker": "MCK",
    "name": "McKesson Corporation NYSE",
    "price": "$880.86",
    "change": "-1.21%",
    "url": "https://clearank.com/stock/mck-stock-analysis/"
   },
   {
    "ticker": "JNJ",
    "name": "Johnson & Johnson NYSE",
    "price": "$265.63",
    "change": "-0.2703%",
    "url": "https://clearank.com/stock/johnson-johnson-jnj/"
   },
   {
    "ticker": "LEGN",
    "name": "Legend Biotech Corporation NASDAQ",
    "price": "$19.91",
    "change": "-2.83%",
    "url": "https://clearank.com/stock/legend-biotech-legn/"
   }
  ],
  "comparisons": [
   {
    "ticker": "SCHD vs VOO Comparison",
    "name": "",
    "url": "https://clearank.com/compare/schd-vs-voo/"
   },
   {
    "ticker": "AMD vs MU Comparison",
    "name": "",
    "url": "https://clearank.com/compare/amd-vs-mu/"
   },
   {
    "ticker": "VTI vs VT Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vti-vs-vt/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "CCI",
    "text": "Crown Castle Inc.",
    "url": "https://clearank.com/stock/cci-stock-analysis/"
   },
   {
    "ticker": "AME",
    "text": "AMETEK, Inc.",
    "url": "https://clearank.com/stock/ame-stock-analysis/"
   },
   {
    "ticker": "VRSK",
    "text": "Verisk Analytics, Inc.",
    "url": "https://clearank.com/stock/vrsk-stock-analysis/"
   },
   {
    "ticker": "DEO",
    "text": "Diageo plc Sponsored",
    "url": "https://clearank.com/stock/deo-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "AERO/USD",
    "text": "↑ 8.90%",
    "url": "https://clearank.com/crypto/aero-usd-crypto-analysis/"
   },
   {
    "ticker": "HUT",
    "text": "↑ 8.77%",
    "url": "https://clearank.com/stock/hut-stock-analysis/"
   },
   {
    "ticker": "MRNA",
    "text": "↑ 8.44%",
    "url": "https://clearank.com/stock/moderna-mrna/"
   },
   {
    "ticker": "REPL",
    "text": "↓ 8.37%",
    "url": "https://clearank.com/stock/repl-stock-analysis/"
   },
   {
    "ticker": "ALGO/USD",
    "text": "↓ 8.21%",
    "url": "https://clearank.com/crypto/algorand-algo-usd/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "GEHC",
    "text": "GE HealthCare",
    "url": "https://clearank.com/stock/ge-healthcare-gehc/"
   },
   {
    "ticker": "MDT",
    "text": "Medtronic plc",
    "url": "https://clearank.com/stock/medtronic-mdt/"
   },
   {
    "ticker": "NEOG",
    "text": "Neogen Corporation",
    "url": "https://clearank.com/stock/neogen-neog/"
   },
   {
    "ticker": "QDEL",
    "text": "QuidelOrtho Corporation",
    "url": "https://clearank.com/stock/quidelortho-qdel/"
   },
   {
    "ticker": "SYK",
    "text": "Stryker Corporation",
    "url": "https://clearank.com/stock/stryker-syk/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/OFIX-orthofix-medical-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/OFIX-orthofix-medical-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "Orthofix Medical (OFIX) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/ofix-stock-analysis/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/ofix-stock-analysis/",
        "name": "Orthofix Medical (OFIX) Stock Price Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/ofix-stock-analysis/#webpage",
     "url": "https://clearank.com/stock/ofix-stock-analysis/",
     "name": "Orthofix Medical (OFIX) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-22T09:35:25+00:00",
     "dateModified": "2026-09-11T20:37:46+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/OFIX-orthofix-medical-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/ofix-stock-analysis/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Orthofix Medical (OFIX) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-22T09:35:25+00:00",
     "dateModified": "2026-09-11T20:37:46+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Orthofix Medical Inc. (OFIX) stock: Healthcare, Medical Devices. $360M market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "name": "Orthofix Medical (OFIX) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/ofix-stock-analysis/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/ofix-stock-analysis/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/OFIX-orthofix-medical-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/ofix-stock-analysis/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Orthofix Medical Inc. (OFIX)",
   "tickerSymbol": "OFIX",
   "url": "https://clearank.com/stock/ofix-stock-analysis/",
   "description": "AI-powered financial analysis for Orthofix Medical Inc. (OFIX) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NASDAQ",
   "offers": {
    "@type": "Offer",
    "price": 8.91,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/ofix-stock-analysis/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is Orthofix Medical Inc.'s stock forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Orthofix Medical Inc.'s stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $7.07, with a downside scenario at $2.43 and an upside scenario at $20.58. These figures represent statistical outcomes and are not guaranteed price targets."
     }
    },
    {
     "@type": "Question",
     "name": "Is Orthofix Medical Inc. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Orthofix Medical Inc. (OFIX) is currently rated a 'Hold' by Wall Street analysts, with a median price target of $13.00, suggesting a 45.9% upside from its current price of $8.91. The stock is technically oversold, but its negative EPS and below-sector-average revenue growth present considerable risks."
     }
    },
    {
     "@type": "Question",
     "name": "What are the biggest risks facing Orthofix Medical Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The primary risks for Orthofix Medical Inc. include its ongoing negative earnings per share, revenue growth that lags its healthcare sector peers, and a bearish technical trend indicated by its position below key moving averages. The company's ability to achieve consistent profitability and outpace sector growth are critical factors."
     }
    },
    {
     "@type": "Question",
     "name": "How did Orthofix Medical Inc. perform in its latest earnings report?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "In its latest earnings report on August 5, 2026, Orthofix Medical Inc. reported an EPS of $0.07, significantly beating the estimated -$0.03 by 333.33%. This positive surprise led to a 1.73% increase in the stock price."
     }
    },
    {
     "@type": "Question",
     "name": "What is the consensus rating for OFIX stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The consensus rating for OFIX stock among Wall Street analysts is 'Hold', supported by a consensus score of 70 out of 100. This rating reflects a balanced view among the five analysts covering the company."
     }
    },
    {
     "@type": "Question",
     "name": "Are insiders buying Orthofix Medical Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Yes, insiders are net buyers of Orthofix Medical Inc. stock, with total purchases of $5.5 million compared to $3.7 million in sales. This activity, particularly from ENGINE CAPITAL MANAGEMENT, L.L.C., has resulted in a 'Slight Buy Signal' according to insider transaction data."
     }
    },
    {
     "@type": "Question",
     "name": "How does Orthofix Medical Inc. compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Orthofix Medical Inc.'s revenue growth of 3.8% is below the Healthcare sector median of 8.1%, and its P/E ratio of -6.02 (negative due to EPS of $-1.48). Its Return on Equity (ROE) is also negative compared to the sector's median of 6.9%."
     }
    }
   ]
  }
 ]
}